Coagulation Markers Market Outlook (2023 to 2033)

The coagulation markers market size is projected to be worth US$ 1.21 billion in 2023. The market is likely to surpass US$ 2.22 billion by 2033 at a CAGR of 6.3% during the forecast period. Growing surgical orthopedic procedures, such as venous thromboembolism (VTE), have resulted in a market increase. According to several studies on preoperative risk assessment, the majority of patients undergoing major orthopedic surgery would be hypercoagulable. The use of coagulation markers in the screening of VTE has proven to be quite successful in detecting coagulation activation.

Other Drivers Propelling the Demand for Coagulation Markers include:

  • The rising prevalence of Ischemic Stroke is driving market expansion. According to the WHO Global Stroke Factsheet produced in 2022, the lifetime risk of getting a stroke has increased by 50%. Coagulation markers can detect coagulation system activity in stroke patients, which is helping to meet the growing need.
  • Persistent coagulation abnormalities appear to increase the likelihood of a wide range of non-AIDS-defining consequences. Several studies found that plasma D-dimer levels, a fibrinolysis marker, independently predicted morbidity in HIV-infected individuals. These factors assist to market growth.
  • Coagulation indicators are critical in identifying individuals who may benefit from certain treatment measures, such as genetically tailored anticoagulant dose. Precision therapies seek to improve efficacy while minimizing side effects by optimizing treatment options based on an individual's coagulation marker profile.

Challenges for Companies /Manufacturers in the Coagulation Markers Market:

  • Many coagulation indicators are not disease- or condition-specific. Marker levels can be elevated or lowered in many coagulation diseases, making it difficult to establish the specific reason.
  • Coagulation markers give a snapshot of this dynamic system, but understanding the interaction of numerous components is required for interpretation. Interactions between several indicators and their diagnostic relevance might be complex, making interpretation difficult.
  • Coagulation markers may have unique detection time requirements. D-dimer levels, for example, may not be enhanced immediately after the commencement of a thrombotic episode, necessitating optimal testing time.

Opportunities in the Coagulation Markers Industry:

  • Coagulation indicators can help in the early identification of coagulation problems, allowing for the beginning of treatment and management to begin as soon as possible. Healthcare practitioners can analyze an individual's risk profile and establish personalized preventative treatments by identifying particular indicators linked with thrombotic or bleeding tendencies.
  • Coagulation indicators can be used with other diagnostic modalities, such as imaging or genetic testing, to offer a more complete picture of coagulation diseases. Combining several markers and diagnostic techniques can improve diagnosis accuracy, help with treatment decisions, and make patient management easier.
  • Coagulation markers have the potential to develop personalized treatment in the field of coagulation diseases. Through marker analysis, healthcare practitioners may personalize treatment plans for individuals who may benefit from various therapeutic measures by understanding an individual's coagulation profile.

Latest Trends in the Coagulation Markers Market:

  • There is considerable interest in creating coagulation marker tests that may be used at the point of care, such as at the bedside or in outpatient settings. A major trend in the area is the development of portable and user-friendly coagulation marker testing instruments, which is increasing access to diagnostics in a variety of healthcare settings.
  • Collaboration between researchers, doctors, and regulatory agencies is critical for progressing coagulation marker research and encouraging standardized practices. To increase the reliability and comparability of coagulation marker results, collaborative networks promote data sharing, information exchange, and consensus-building.
Attributes Details
Coagulation Markers Market Size (2023) US$ 1.21 billion
Coagulation Markers Market Projected Size (2033) US$ 2.22 billion
Value CAGR (2023 to 2033) 6.2%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2012 to 2022 Coagulation Markers Demand Outlook Compared to 2023 to 2033 Forecast

From 2012 to 2022, the global coagulation markers market experienced a CAGR of 3.5%, reaching a market size of US$ 1.21 billion in 2023. The increased frequency of coagulation diseases such as DVT, PE, and hemophilia has been a key driver for the coagulation markers industry. Because these illnesses are associated with anomalies in blood coagulation, there is a rising demand for coagulation indicators for diagnostic and monitoring purposes.

Increasing identification and diagnosis of coagulation abnormalities has resulted from increasing awareness of these illnesses, as well as enhanced diagnostic skills. Because healthcare personnel are now better trained to diagnose coagulation abnormalities, coagulation indicators are being used for diagnostic purposes. Early identification and management can enhance patient outcomes, propelling the industry forward.

Future Forecast for Coagulation Markers Industry:

Looking ahead, the global coagulation markers industry is expected to rise at a CAGR of 6.3% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 2.22 billion.

The coagulation markers industry is expected to continue its growth trajectory from 2023 to 2033. Continuous technological improvements, such as the development of innovative assays, point-of-care testing devices, and high-throughput automated analyzers, will fuel market expansion. These developments will increase the sensitivity, accuracy, and efficiency of coagulation marker testing, resulting in improved diagnostic capabilities and simpler processes.

The rise of personalized medicine and tailored therapeutics will drive up demand for coagulation indicators. By analyzing coagulation indicators, healthcare practitioners may personalize treatment strategies based on an individual's unique coagulation profile, improving therapeutic results while reducing the risk of bleeding or thrombotic events.

Comparative View of the Coagulation Markers Market

Coagulation Markers Market:

Attributes Coagulation Markers Market
CAGR (2023 to 2033) 6.3%
Market Value (2033) US$ 2.22 billion
Opportunity Coagulation indicators can be used with other diagnostic modalities, such as imaging or genetic testing, to offer a more complete picture of coagulation diseases. Combining several markers and diagnostic techniques can improve diagnosis accuracy, help with treatment decisions, and make patient management easier.
Key Trends Collaboration between researchers, doctors, and regulatory agencies is critical for progressing coagulation marker research and encouraging standardized practices. To increase the reliability and comparability of coagulation marker results, collaborative networks promote data sharing, information exchange, and consensus-building.

Renal Biomarker Market:

Attributes Renal Biomarker Market
CAGR (2023 to 2033) 7.4%
Market Value (2033) US$ 2.8 billion
Opportunity Advancements in molecular diagnostic techniques and early-specific biomarkers of CKD diagnosis to bolster market growth.
Key Trends Omics techniques are gradually becoming acknowledged for their significance in the early diagnosis of CKD, although not being frequently.

Blood Coagulation Analyzers Market:

Attributes Blood Coagulation Analyzers Market
CAGR (2023 to 2033) 6.5%
Market Value (2033) US$ 6.1 billion
Opportunity Rise in cardiovascular diseases with underlying obesity expected to be the most pivotal aspect driving the market.
Key Trends Key manufacturers in the market are introducing innovative analyzers that are tiny and simple to integrate, to be used in variety of medical facilities.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-Wise Insights

Coagulation Markers Market to Surge in the United States amid Increasing Prevalence of Coagulation Disorders

Country The United States
Market Size (US$ billion) by End of Forecast Period (2033) US$ 731.3 million
CAGR % 2023 to End of Forecast (2033) 7.3%

The coagulation markers industry in the United States is expected to reach a market value of US$ 731.3 million by 2033, expanding at a CAGR of 7.3%. The United States continues to experience rapid growth in market due to increasing prevalence of coagulation disorders. The prevalence of coagulation diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), and other thrombotic illnesses has increased in the United States. As a result, there is a greater need for coagulation indicators for the early identification, diagnosis, and monitoring of these illnesses.

Rising Aging Population to Propel the United Kingdom Market Growth.

Country The United Kingdom
Market Size (US$ billion) by End of Forecast Period (2033) US$ 160.8 million
CAGR % 2023 to End of Forecast (2033) 9.4%

The coagulation markers industry in the United Kingdom is expected to reach a market value of US$ 160.8 million, expanding at a CAGR of 9.4% during the forecast period. The United Kingdom market is projected to experience growth owing to the rising aging population. The United Kingdom has an ageing population, with an increasing number of older people. Advanced age increases the risk of coagulation diseases such atrial fibrillation, venous thromboembolism, and stroke. Coagulation marker testing is becoming more popular as the population ages in order to determine the risk of thrombotic events and guide anticoagulant medication.

China's Expansion and Prioritization of Research and Development will lead to Market Growth in the Country.

Country China
Market Size (US$ billion) by End of Forecast Period (2033) US$ 276.6 million
CAGR % 2023 to End of Forecast (2033) 9.0%

The coagulation markers industry in China is anticipated to reach a market value of US$ 276.6 million, moving at a CAGR of 9.0% during the forecast period. The coagulation markers industry in China is expected to grow prominently due to the increasing research and development. The long-term socioeconomic growth of China is being centered on scientific and technical innovation, which the Chinese government is promoting through financing, reform, and societal prestige. China's 14th five-year plan (2021-2025) is focused on pursuing innovation-driven growth and aims for research and development investment to expand by more than 7% annually over that time.

The top scientific magazine, Nature Index 2020 Annual Tables, reports that China's contribution to worldwide natural science research climbed by 15% in 2020. The country's favorable environment ensures that the advances in research production witnessed in previous years will continue.

Rigorous Research and Development Efforts Have Led Japan to Develop and Innovate Novel Coagulation Markers.

Country Japan
Market Size (US$ billion) by End of Forecast Period (2033) US$ 127.3 million
CAGR % 2023 to End of Forecast (2033) 6.6%

The coagulation markers industry in Japan is estimated to reach a market value of US$ 127.3 million by 2033, thriving at a CAGR of 6.6%. The market in Japan is predicted to grow because of the growing demand for novel therapies. Ongoing research and development activities focusing on the development of novel coagulation markers, enhanced testing procedures, and customized assays for the Japanese population have aided market expansion. Collaborations among pharmaceutical firms, research institutes, and healthcare providers foster innovation and the development of enhanced coagulation marker testing.

Demand for Coagulation Markers Market is Rising Due to Strong Healthcare Infrastructure.

Country South Korea
Market Size (US$ billion) by End of Forecast Period (2033) US$ 74.1 million
CAGR % 2023 to End of Forecast (2033) 5.9%

The coagulation markers industry in South Korea is expected to reach a market value of US$ 74.1 million, expanding at a CAGR of 5.9% during the forecast period. The market in South Korea is forecasted to witness growth due to the high healthcare expenditure. South Korea spends a lot on healthcare, and the investment in diagnostics and laboratory testing is growing. Coagulation marker tests are an essential aspect of diagnosing coagulation disorders. Coagulation markers market expansion is further aided by the availability of healthcare insurance coverage and reimbursement policies.

Category-Wise Insights

D-dimer Assay to Dominate Coagulation Markers Industry with 5.4% CAGR through 2033

The D-dimer assay is expected to dominate the coagulation markers industry with a CAGR of 5.4% from 2023 to 2033. By-products of blood coagulation and breakdown, such as the D-dimer, can be detected via analysis of a blood sample. D-dimer is produced when a blood clot starts to dissolve. This explains why D-dimer test has a large market share.

When a doctor suspects that anything other than DVT or PE is the cause of the symptoms, D-dimer is extremely helpful. It is an efficient, non-invasive method to assist in ruling out irregular or excessive clotting as the underlying reason.

How the Plasma Is Driving the Coagulation Markers Market?

The plasma is expected to dominate the coagulation markers industry with a CAGR of 6.2% from 2022 to 2033.

Since plasma has a high quantity of fibrinogen, this method of detecting coagulation is frequently used. Along with other procoagulants like thrombin and factor X, fibrinogen is one of the main players in the process of blood clotting. The use of plasma as a specimen for coagulation tests is increasing as a result of this factor.

ELISA to Dominate Coagulation Markers Industry with 5.4% CAGR through 2033

The ELISA is expected to dominate the coagulation markers industry with a CAGR of 5.4% from 2023 to 2033. The Human Coagulation Factor XII ELISA kit is intended for measuring coagulation factor XII levels in plasma. ELISA kits include recombinant monoclonal antibodies for specific and sensitive findings, as well as a single-wash technique that reduces test time to 90 minutes. The demand for ELISA kits is being driven by the shortened test time and effective outcomes.

Which Application is leading the Coagulation Markers Market?

Disseminated intravascular coagulation (DIC) is expected to dominate in the application segment with a CAGR of 6.7% from 2023 to 2033. Due to the rising incidence of cancer, it is projected that the market for diffused intravascular coagulation (DIC) would expand quickly over the forecast period. By 2040, the International Agency for Research on Cancer (IARC) projects that there will be 16.3 million cancer-related deaths and 27.5 million new cases worldwide. One of the main causes of disseminated intravascular coagulation (DIC) is cancer. Blood clotting proteins become overactive in a dangerous disorder known as diffused intravascular coagulation (DIC).

Which Segment is Expected to Lead the ‘Purpose’ Category Throughout the Forecast Period?

By purpose, clinical use segment is expected to continue leading the market over a CAGR of 6.0% throughout the projected timeframe. Coagulation tests have been shown to be clinically useful in the detection of cardiovascular illnesses and coagulation disorders, particularly DVT. Coagulant levels in the circulation increase dramatically in response to various illnesses, making it an important indicator for diagnosis. Because of their diagnostic usefulness, Coagulation tests are now widely used in clinical practice to guide antibiotic treatment and help clinical decision-making.

Which End User Is Leading The Coagulation Markers Market?

The hospitals have led the coagulation markers market as the leading end user with the CAGR of 7.4% in 2023 to 2033. Hospitals are the principal providers of acute care, serving a diverse variety of patients, including those suffering from severe chronic illnesses, coagulation problems, and other urgent circumstances. Coagulation tests are extremely useful in these conditions, assisting in the diagnosis, monitoring, and treatment of cardiovascular disorders. In these acute care circumstances, hospitals rely on coagulation tests to assist clinical decision-making, guide antibiotic treatment, and assess patient prognosis.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

How Key Players Stay Competitive in the Coagulation Markers Industry?

The coagulation markers industry is highly competitive, with numerous players vying for market share. In such a scenario, key players must adopt effective strategies to stay ahead of the competition.

Key Strategies Adopted by the Players

  • Product Development

Companies invest heavily in research and development to deliver novel products that improve efficiency, dependability, and cost-effectiveness. Product innovation allows businesses to differentiate themselves from their competition while also catering to the changing demands of their clients.

  • Strategic Alliances & Collaborations

Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.

  • Expansion into Emerging Markets

The coagulation markers sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.

  • Mergers and Acquisitions

Mergers and acquisitions are frequently used by key players in the coagulation markers business to consolidate their market position, increase their product portfolio, and gain access to new markets.

Key Players in the Coagulation Markers Industry

  • Accuquik™ Test Kits
  • CTK Biotech, Inc.
  • Siemens Healthcare Private Limited
  • Quidel Corporation
  • Eurolyser Diagnostica GmbH
  • Goldsite Diagnostics Inc
  • Diazyme Laboratories, Inc
  • Hipro Biotechnology Co.,Ltd.

Key Developments in the Coagulation Markers Market:

  • On Jan. 20, 2023, Diazyme Laboratories, Inc. and Carolina Liquid Chemistries Corp. to reveal a partnership to increase the testing menu for the Diazyme DZ-Lite c270 tabletop clinical chemistry analyzer.

Segmentation Analysis of the Coagulation Markers Market

By Product:

  • D-dimer Assay
  • Fibrinogen Assay

By Sample Type:

  • Plasma
  • Whole Blood Sample
  • Other

By Technology:

  • Fluorescence Immunoassay
  • ELISA
  • Rapid Test
  • Particle-enhanced Immunoturbidimetric assay

By Application:

  • Deep Venous Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Disseminated Intravascular Coagulation (DIC)
  • Trauma
  • Others

By Purpose:

  • Clinical Use
  • Research Use Only

By End User:

  • Hospital
  • Specialty Clinics
  • Academic and Research Institute
  • Diagnostics Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

Frequently Asked Questions

Which are the Key Asian Countries in the Coagulation Markers Market?

China, India, Japan dominate the market in Asia Pacific.

Which Industry is the Key Consumer of Coagulation Markers Market?

The healthcare sector is the main consumer of coagulation indicators.

What is the Growth Outlook of the United States in the Coagulation Markers Market?

The United States is predicted to record a CAGR of 5% from 2023 to 2033.

What is Current Market Valuation of Coagulation Markers Market?

The global coagulation markers market was valued at US$ 1.21 billion in 2023

How Big will be the Coagulation Markers Market by 2033?

The global coagulation markers market is projected to reach US$ 2.22 billion by 2033.

Table of Content
1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value Added Insights

    4.1. Product Adoption/ Usage Analysis

    4.2. Product USPs/ Features

    4.3. Technological Roadmap

    4.4. Regulatory Landscape

    4.5. PESTEL Analysis

    4.6. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Key Player’s Historic Growth

        5.2.2. Reimbursements Policies

        5.2.3. Prevalence of Coagulation Disorders

        5.2.4. Increasing Preference for Better Diagnostic And Monitoring Technologies

        5.2.5. Frequency of Product Approvals

        5.2.6. Strategic Collaborations Among Players

    5.3. Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Volume (in Units) Analysis, 2012 to 2022

    6.2. Current and Future Volume (in Units) Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Product

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033

    8.1. Historical Market Value (US$ Million) and Volume (Units) Analysis, 2012 to 2022

    8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2012 to 2022

    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        9.3.1. D-dimer Assay

        9.3.2. Fibrinogen Assay

    9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2012 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033

        10.3.1. Plasma

        10.3.2. Whole Blood Sample

        10.3.3. Other

    10.4. Market Attractiveness Analysis By Sample Type

11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Technology

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By Technology, 2012 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technology, 2023 to 2033

        11.3.1. Fluorescence Immunoassay

        11.3.2. ELISA

        11.3.3. Rapid Test

        11.3.4. Particle-enhanced Immunoturbidimetric Assay

    11.4. Market Attractiveness Analysis By Technology

12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Application

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By Application, 2012 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        12.3.1. Deep Venous Thrombosis (DVT)

        12.3.2. Pulmonary Embolism (PE)

        12.3.3. Disseminated Intravascular Coagulation (DIC)

        12.3.4. Trauma

        12.3.5. Others

    12.4. Market Attractiveness Analysis By Application

13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Purpose

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Million) Analysis By Purpose, 2012 to 2022

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Purpose, 2023 to 2033

        13.3.1. Clinical Use

        13.3.2. Research Use Only

    13.4. Market Attractiveness Analysis By Purpose

14. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022

    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        14.3.1. Hospital

        14.3.2. Specialty Clinics

        14.3.3. Academic and Research Institutes

        14.3.4. Diagnostics Laboratories

    14.4. Market Attractiveness Analysis By End User

15. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2012 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        15.3.1. North America

        15.3.2. Latin America

        15.3.3. Europe

        15.3.4. South Asia

        15.3.5. East Asia

        15.3.6. Oceania

        15.3.7. Middle East and Africa (Middle East & Africa)

    15.4. Market Attractiveness Analysis By Region

16. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. USA

            16.3.1.2. Canada

        16.3.2. By Product

        16.3.3. By Sample Type

        16.3.4. By Technology

        16.3.5. By Application

        16.3.6. By Purpose

        16.3.7. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Sample Type

        16.4.4. By Technology

        16.4.5. By Application

        16.4.6. By Purpose

        16.4.7. By End User

    16.5. Country Level Analysis & Forecast

        16.5.1. USA Market Analysis

            16.5.1.1. Introduction

            16.5.1.2. Market Analysis and Forecast by Market Taxonomy

                16.5.1.2.1. By Product

                16.5.1.2.2. By Sample Type

                16.5.1.2.3. By Technology

                16.5.1.2.4. By Application

                16.5.1.2.5. By Purpose

                16.5.1.2.6. By End User

        16.5.2. Canada Market Analysis

            16.5.2.1. Introduction

            16.5.2.2. Market Analysis and Forecast by Market Taxonomy

                16.5.2.2.1. By Product

                16.5.2.2.2. By Sample Type

                16.5.2.2.3. By Technology

                16.5.2.2.4. By Application

                16.5.2.2.5. By Purpose

                16.5.2.2.6. By End User

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

17. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. Brazil

            17.3.1.2. Mexico

            17.3.1.3. Argentina

            17.3.1.4. Rest of Latin America

        17.3.2. By Product

        17.3.3. By Sample Type

        17.3.4. By Technology

        17.3.5. By Application

        17.3.6. By Purpose

        17.3.7. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Sample Type

        17.4.4. By Technology

        17.4.5. By Application

        17.4.6. By Purpose

        17.4.7. By End User

    17.5. Country Level Analysis & Forecast

        17.5.1. Brazil Market Analysis

            17.5.1.1. Introduction

            17.5.1.2. Market Analysis and Forecast by Market Taxonomy

                17.5.1.2.1. By Product

                17.5.1.2.2. By Sample Type

                17.5.1.2.3. By Technology

                17.5.1.2.4. By Application

                17.5.1.2.5. By Purpose

                17.5.1.2.6. By End User

        17.5.2. Mexico Market Analysis

            17.5.2.1. Introduction

            17.5.2.2. Market Analysis and Forecast by Market Taxonomy

                17.5.2.2.1. By Product

                17.5.2.2.2. By Sample Type

                17.5.2.2.3. By Technology

                17.5.2.2.4. By Application

                17.5.2.2.5. By Purpose

                17.5.2.2.6. By End User

        17.5.3. Argentina Market Analysis

            17.5.3.1. Introduction

            17.5.3.2. Market Analysis and Forecast by Market Taxonomy

                17.5.3.2.1. By Product

                17.5.3.2.2. By Sample Type

                17.5.3.2.3. By Technology

                17.5.3.2.4. By Application

                17.5.3.2.5. By Purpose

                17.5.3.2.6. By End User

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

18. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. Germany

            18.3.1.2. France

            18.3.1.3. Italy

            18.3.1.4. UK

            18.3.1.5. Spain

            18.3.1.6. Russia

            18.3.1.7. BENELUX

            18.3.1.8. Rest of Europe

        18.3.2. By Product

        18.3.3. By Sample Type

        18.3.4. By Technology

        18.3.5. By Application

        18.3.6. By Purpose

        18.3.7. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Sample Type

        18.4.4. By Technology

        18.4.5. By Application

        18.4.6. By Purpose

        18.4.7. By End User

    18.5. Country Level Analysis & Forecast

        18.5.1. Germany Market Analysis

            18.5.1.1. Introduction

            18.5.1.2. Market Analysis and Forecast by Market Taxonomy

                18.5.1.2.1. By Product

                18.5.1.2.2. By Sample Type

                18.5.1.2.3. By Technology

                18.5.1.2.4. By Application

                18.5.1.2.5. By Purpose

                18.5.1.2.6. By End User

        18.5.2. France Market Analysis

            18.5.2.1. Introduction

            18.5.2.2. Market Analysis and Forecast by Market Taxonomy

                18.5.2.2.1. By Product

                18.5.2.2.2. By Sample Type

                18.5.2.2.3. By Technology

                18.5.2.2.4. By Application

                18.5.2.2.5. By Purpose

                18.5.2.2.6. By End User

        18.5.3. Italy Market Analysis

            18.5.3.1. Introduction

            18.5.3.2. Market Analysis and Forecast by Market Taxonomy

                18.5.3.2.1. By Product

                18.5.3.2.2. By Sample Type By Technology

                18.5.3.2.3. By Application

                18.5.3.2.4. By Purpose

                18.5.3.2.5. By End User

        18.5.4. UK Market Analysis

            18.5.4.1. Introduction

            18.5.4.2. Market Analysis and Forecast by Market Taxonomy

                18.5.4.2.1. By Product

                18.5.4.2.2. By Sample Type

                18.5.4.2.3. By Technology

                18.5.4.2.4. By Application

                18.5.4.2.5. By Purpose

                18.5.4.2.6. By End User

        18.5.5. Spain Market Analysis

            18.5.5.1. Introduction

            18.5.5.2. Market Analysis and Forecast by Market Taxonomy

                18.5.5.2.1. By Product

                18.5.5.2.2. By Sample Type

                18.5.5.2.3. By Technology

                18.5.5.2.4. By Application

                18.5.5.2.5. By Purpose

                18.5.5.2.6. By End User

        18.5.6. Russia Market Analysis

            18.5.6.1. Introduction

            18.5.6.2. Market Analysis and Forecast by Market Taxonomy

                18.5.6.2.1. By Product

                18.5.6.2.2. By Sample Type

                18.5.6.2.3. By Technology

                18.5.6.2.4. By Application

                18.5.6.2.5. By Purpose

                18.5.6.2.6. By End User

        18.5.7. BENELUX Market Analysis

            18.5.7.1. Introduction

            18.5.7.2. Market Analysis and Forecast by Market Taxonomy

                18.5.7.2.1. By Product

                18.5.7.2.2. By Sample Type

                18.5.7.2.3. By Technology

                18.5.7.2.4. By Application

                18.5.7.2.5. By Purpose

                18.5.7.2.6. By End User

    18.6. Market Trends

    18.7. Key Market Participants - Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

19. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. India

            19.3.1.2. Thailand

            19.3.1.3. Indonesia

            19.3.1.4. Malaysia

            19.3.1.5. Rest of South Asia

        19.3.2. By Product

        19.3.3. By Sample Type

        19.3.4. By Technology

        19.3.5. By Application

        19.3.6. By Purpose

        19.3.7. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Sample Type

        19.4.4. By Technology

        19.4.5. By Application

        19.4.6. By Purpose

        19.4.7. By End User

    19.5. Country Level Analysis & Forecast

        19.5.1. India Market Analysis

            19.5.1.1. Introduction

            19.5.1.2. Market Analysis and Forecast by Market Taxonomy

                19.5.1.2.1. By Product

                19.5.1.2.2. By Sample Type

                19.5.1.2.3. By Technology

                19.5.1.2.4. By Application

                19.5.1.2.5. By Purpose

                19.5.1.2.6. By End User

        19.5.2. Thailand Market Analysis

            19.5.2.1. Introduction

            19.5.2.2. Market Analysis and Forecast by Market Taxonomy

                19.5.2.2.1. By Product

                19.5.2.2.2. By Sample Type

                19.5.2.2.3. By Technology

                19.5.2.2.4. By Application

                19.5.2.2.5. By Purpose

                19.5.2.2.6. By End User

        19.5.3. Indonesia Market Analysis

            19.5.3.1. Introduction

            19.5.3.2. Market Analysis and Forecast by Market Taxonomy

                19.5.3.2.1. By Product

                19.5.3.2.2. By Sample Type

                19.5.3.2.3. By Technology

                19.5.3.2.4. By Application

                19.5.3.2.5. By Purpose

                19.5.3.2.6. By End User

        19.5.4. Malaysia Market Analysis

            19.5.4.1. Introduction

            19.5.4.2. Market Analysis and Forecast by Market Taxonomy

                19.5.4.2.1. By Product

                19.5.4.2.2. By Sample Type

                19.5.4.2.3. By Technology

                19.5.4.2.4. By Application

                19.5.4.2.5. By Purpose

                19.5.4.2.6. By End User

    19.6. Market Trends

    19.7. Key Market Participants - Intensity Mapping

    19.8. Drivers and Restraints - Impact Analysis

20. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        20.3.1. By Country

            20.3.1.1. China

            20.3.1.2. Japan

            20.3.1.3. South Korea

        20.3.2. By Product

        20.3.3. By Sample Type

        20.3.4. By Technology

        20.3.5. By Application

        20.3.6. By Purpose

        20.3.7. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Product

        20.4.3. By Sample Type

        20.4.4. By Technology

        20.4.5. By Application

        20.4.6. By Purpose

        20.4.7. By End User

    20.5. Country Level Analysis & Forecast

        20.5.1. China Market Analysis

            20.5.1.1. Introduction

            20.5.1.2. Market Analysis and Forecast by Market Taxonomy

                20.5.1.2.1. By Product

                20.5.1.2.2. By Sample Type

                20.5.1.2.3. By Technology

                20.5.1.2.4. By Application

                20.5.1.2.5. By Purpose

                20.5.1.2.6. By End User

        20.5.2. Japan Market Analysis

            20.5.2.1. Introduction

            20.5.2.2. Market Analysis and Forecast by Market Taxonomy

                20.5.2.2.1. By Product

                20.5.2.2.2. By Sample Type

                20.5.2.2.3. By Technology

                20.5.2.2.4. By Application

                20.5.2.2.5. By Purpose

                20.5.2.2.6. By End User

        20.5.3. South Korea Market Analysis

            20.5.3.1. Introduction

            20.5.3.2. Market Analysis and Forecast by Market Taxonomy

                20.5.3.2.1. By Product

                20.5.3.2.2. By Sample Type

                20.5.3.2.3. By Technology

                20.5.3.2.4. By Application

                20.5.3.2.5. By Purpose

                20.5.3.2.6. By End User

    20.6. Market Trends

    20.7. Key Market Participants - Intensity Mapping

    20.8. Drivers and Restraints - Impact Analysis

21. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    21.1. Introduction

    21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        21.3.1. By Country

            21.3.1.1. Australia

            21.3.1.2. New Zealand

        21.3.2. By Product

        21.3.3. By Sample Type

        21.3.4. By Technology

        21.3.5. By Application

        21.3.6. By Purpose

        21.3.7. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Country

        21.4.2. By Product

        21.4.3. By Sample Type

        21.4.4. By Technology

        21.4.5. By Application

        21.4.6. By Purpose

        21.4.7. By End User

    21.5. Country Level Analysis & Forecast

        21.5.1. Australia Market Analysis

            21.5.1.1. Introduction

            21.5.1.2. Market Analysis and Forecast by Market Taxonomy

                21.5.1.2.1. By Product

                21.5.1.2.2. By Sample Type

                21.5.1.2.3. By Technology

                21.5.1.2.4. By Application

                21.5.1.2.5. By Purpose

                21.5.1.2.6. By End User

        21.5.2. New Zealand Market Analysis

            21.5.2.1. Introduction

            21.5.2.2. Market Analysis and Forecast by Market Taxonomy

                21.5.2.2.1. By Product

                21.5.2.2.2. By Sample Type

                21.5.2.2.3. By Technology

                21.5.2.2.4. By Application

                21.5.2.2.5. By Purpose

                21.5.2.2.6. By End User

    21.6. Market Trends

    21.7. Key Market Participants - Intensity Mapping

    21.8. Drivers and Restraints - Impact Analysis

22. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    22.1. Introduction

    22.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    22.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        22.3.1. By Country

            22.3.1.1. GCC Countries

            22.3.1.2. Türkiye

            22.3.1.3. Northern Africa

            22.3.1.4. South Africa

            22.3.1.5. Rest of Middle East and Africa

        22.3.2. By Product

        22.3.3. By Sample Type

        22.3.4. By Technology

        22.3.5. By Application

        22.3.6. By Purpose

        22.3.7. By End User

    22.4. Market Attractiveness Analysis

        22.4.1. By Country

        22.4.2. By Product

        22.4.3. By Sample Type

        22.4.4. By Technology

        22.4.5. By Application

        22.4.6. By Purpose

        22.4.7. By End User

    22.5. Country Level Analysis & Forecast

        22.5.1. GCC Countries Market Analysis

            22.5.1.1. Introduction

            22.5.1.2. Market Analysis and Forecast by Market Taxonomy

                22.5.1.2.1. By Product

                22.5.1.2.2. By Sample Type

                22.5.1.2.3. By Technology

                22.5.1.2.4. By Application

                22.5.1.2.5. By Purpose

                22.5.1.2.6. By End User

        22.5.2. Türkiye Market Analysis

            22.5.2.1. Introduction

            22.5.2.2. Market Analysis and Forecast by Market Taxonomy

                22.5.2.2.1. By Product

                22.5.2.2.2. By Sample Type

                22.5.2.2.3. By Technology

                22.5.2.2.4. By Application

                22.5.2.2.5. By Purpose

                22.5.2.2.6. By End User

        22.5.3. Northern Africa Market Analysis

            22.5.3.1. Introduction

            22.5.3.2. Market Analysis and Forecast by Market Taxonomy

                22.5.3.2.1. By Product

                22.5.3.2.2. By Sample Type

                22.5.3.2.3. By Technology

                22.5.3.2.4. By Application

                22.5.3.2.5. By Purpose

                22.5.3.2.6. By End User

        22.5.4. South Africa Market Analysis

            22.5.4.1. Introduction

            22.5.4.2. Market Analysis and Forecast by Market Taxonomy

                22.5.4.2.1. By Product

                22.5.4.2.2. By Sample Type

                22.5.4.2.3. By Technology

                22.5.4.2.4. By Application

                22.5.4.2.5. By Purpose

                22.5.4.2.6. By End User

    22.6. Market Trends

    22.7. Key Market Participants - Intensity Mapping

    22.8. Drivers and Restraints - Impact Analysis

23. Market Structure Analysis

    23.1. Market Analysis by Tier of Companies

    23.2. Market Share Analysis of Top Players

    23.3. Market Presence Analysis

24. Competition Analysis

    24.1. Competition Dashboard

    24.2. Branding and Promotional Strategies, By Key Players

    24.3. Key Development Analysis

    24.4. Competition Deep Dive

        24.4.1. Accuquik Test Kits

            24.4.1.1. Overview

            24.4.1.2. Product Portfolio

            24.4.1.3. Key Financials

            24.4.1.4. Sales Footprint

            24.4.1.5. SWOT Analysis

            24.4.1.6. Strategy Overview

                24.4.1.6.1. Marketing Strategy

                24.4.1.6.2. Product Strategy

                24.4.1.6.3. Channel Strategy

        24.4.2. CTK Biotech, Inc.

            24.4.2.1. Overview

            24.4.2.2. Product Portfolio

            24.4.2.3. Key Financials

            24.4.2.4. Sales Footprint

            24.4.2.5. SWOT Analysis

            24.4.2.6. Strategy Overview

                24.4.2.6.1. Marketing Strategy

                24.4.2.6.2. Product Strategy

                24.4.2.6.3. Channel Strategy

        24.4.3. Siemens Healthcare Private Limited

            24.4.3.1. Overview

            24.4.3.2. Product Portfolio

            24.4.3.3. Key Financials

            24.4.3.4. Sales Footprint

            24.4.3.5. SWOT Analysis

            24.4.3.6. Strategy Overview

                24.4.3.6.1. Marketing Strategy

                24.4.3.6.2. Product Strategy

                24.4.3.6.3. Channel Strategy

        24.4.4. Quidel Corporation

            24.4.4.1. Overview

            24.4.4.2. Product Portfolio

            24.4.4.3. Key Financials

            24.4.4.4. Sales Footprint

            24.4.4.5. SWOT Analysis

            24.4.4.6. Strategy Overview

                24.4.4.6.1. Marketing Strategy

                24.4.4.6.2. Product Strategy

                24.4.4.6.3. Channel Strategy

        24.4.5. Eurolyser Diagnostica GmbH

            24.4.5.1. Overview

            24.4.5.2. Product Portfolio

            24.4.5.3. Key Financials

            24.4.5.4. Sales Footprint

            24.4.5.5. SWOT Analysis

            24.4.5.6. Strategy Overview

                24.4.5.6.1. Marketing Strategy

                24.4.5.6.2. Product Strategy

                24.4.5.6.3. Channel Strategy

        24.4.6. Goldsite Diagnostics Inc

            24.4.6.1. Overview

            24.4.6.2. Product Portfolio

            24.4.6.3. Key Financials

            24.4.6.4. Sales Footprint

            24.4.6.5. SWOT Analysis

            24.4.6.6. Strategy Overview

                24.4.6.6.1. Marketing Strategy

                24.4.6.6.2. Product Strategy

                24.4.6.6.3. Channel Strategy

        24.4.7. Diazyme Laboratories, Inc

            24.4.7.1. Overview

            24.4.7.2. Product Portfolio

            24.4.7.3. Key Financials

            24.4.7.4. Sales Footprint

            24.4.7.5. SWOT Analysis

            24.4.7.6. Strategy Overview

                24.4.7.6.1. Marketing Strategy

                24.4.7.6.2. Product Strategy

                24.4.7.6.3. Channel Strategy

        24.4.8. Hipro Biotechnology Co.,Ltd.

            24.4.8.1. Overview

            24.4.8.2. Product Portfolio

            24.4.8.3. Key Financials

            24.4.8.4. Sales Footprint

            24.4.8.5. SWOT Analysis

            24.4.8.6. Strategy Overview

                24.4.8.6.1. Marketing Strategy

                24.4.8.6.2. Product Strategy

                24.4.8.6.3. Channel Strategy

25. Assumptions and Acronyms Used

26. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Coagulation Markers Market